Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne University, shared a post on X:
“As we close the year and celebrate together, there is nothing more inspiring than discussing the possibility of a CURE in myeloma. Proud to share our just published editorial in BMT Journal
exploring how science can turn hope into reality.”
Mark Wildgust, Vice President, Global Medical Affairs, Oncology at The Janssen Pharmaceutical Companies of Johnson and Johnson, shared this post, adding:
“Mohamad Mohty terrific editorial. 2025 feels like an inflection as we talk cure.
Peter Voorhees, Luciano J Costa, Marivi Mateos and Sundar Jagannath were all instrumental in presenting CARTITUDE data in 2025, along with MajesTEC-3 all contributing to this discussion of potential cure.”
Title: Toward functional cure in relapsed/refractory multiple myeloma: long-term outcomes from CARTITUDE-1 study cement the role of CAR-T cells
Authors: Teresa de Soto, Nour Moukalled, Mohamad Mohty
You can read the full article in BMT Journal.
